These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 5143403

  • 1. [Secretolytic effect of sobrelol and improvement of pulmonary ventilation in patients with chronic pulmonary tuberculosis associated with chronic bronchitis].
    Bosisio E, Sergi M, Nunziante A, Baudin E.
    G Ital Mal Torace; 1971; 25(3):145-61. PubMed ID: 5143403
    [No Abstract] [Full Text] [Related]

  • 2. [Trial of a new synthetic fluidifying and analeptic agent: sobrerol. Its use in inflammatory bronchopneumopathies].
    Marchioni CF, Monzali G.
    Clin Ter; 1972 Jan 31; 60(2):135-42. PubMed ID: 4401338
    [No Abstract] [Full Text] [Related]

  • 3. [Sobrerol for the treatment of chronic obstructive bronchopneumopathies (clinical and functional observations)].
    Dotta F, Bianchi A.
    Policlinico Med; 1971 Jan 31; 78(2):82-90. PubMed ID: 5564823
    [No Abstract] [Full Text] [Related]

  • 4. [Long-term treatment of the bronchitis syndrome with combinations of a secretolytic agent (Bisolvon-Linctus, Bisulvonamide, Bisolvonmycin)].
    Görlach FW.
    Hippokrates; 1969 Nov 15; 40(21):850-3. PubMed ID: 5382635
    [No Abstract] [Full Text] [Related]

  • 5. [D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses].
    Balzano E, De Gaetani G.
    Minerva Med; 1973 May 25; 64(37):1995-2002. PubMed ID: 4578344
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical trial of a Plantago major preparation in the treatment of chronic bronchitis].
    Matev M, Angelova I, Koĭchev A, Leseva M, Stefanov G.
    Vutr Boles; 1982 May 25; 21(2):133-7. PubMed ID: 7101883
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experiments with a bronchosecretolytic agent].
    Kittel H.
    Med Klin; 1967 Mar 10; 62(10):377-80. PubMed ID: 4874625
    [No Abstract] [Full Text] [Related]

  • 8. [Experiences with the new secretolytic Bisolvon].
    Junge W, Günthner W, Haslreiter E, Hess K, Loos M.
    Med Klin; 1965 Dec 17; 60(51):2058-61. PubMed ID: 5332371
    [No Abstract] [Full Text] [Related]

  • 9. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
    Rossini G.
    Med Monatsschr; 1970 Jun 17; 24(6):270-2. PubMed ID: 5525114
    [No Abstract] [Full Text] [Related]

  • 10. [Secretolytic bisolvon in the treatment of chronic bronchitis and bronchial asthma].
    Beritić T.
    Lijec Vjesn; 1968 Jun 17; 90(8):775-9. PubMed ID: 4888799
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of bronchial reactivity to inhaled coaldust and histamine in normals and in patients with airways obstruction connected with pulmonary tuberculosis or chronic bronchitis.
    Skoogh BE, Simonsson BG.
    Rev Inst Hyg Mines (Hasselt); 1973 Jun 17; 28(4):202-4. PubMed ID: 4804039
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical observations on a new synthetic mucolytic].
    Zacco R, Fornaroli E.
    Clin Ter; 1968 Nov 15; 47(3):247-57. PubMed ID: 4911792
    [No Abstract] [Full Text] [Related]

  • 13. [Chronic bronchitis in intractable pulmonary tuberculosis patients and in those with extended sequelae (function characteristics)].
    Anastasatu C, Baicoianu S, Caracas P, Dutu S.
    Cah Med; 1971 Feb 28; 12(3):205-7. PubMed ID: 5576656
    [No Abstract] [Full Text] [Related]

  • 14. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI, Prozorova VK, Mal'tseva NA, Shatikhina LN.
    Ter Arkh; 2001 Feb 28; 73(3):48-51. PubMed ID: 11417181
    [Abstract] [Full Text] [Related]

  • 15. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG.
    Scand J Respir Dis Suppl; 1974 Feb 28; 90():1-89. PubMed ID: 4618374
    [No Abstract] [Full Text] [Related]

  • 16. [A comparative trial of hemodynamics and pulmonary function in patients with chronic lung disease complicated with or without pulmonary hypertension during exercise].
    Kang J, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Aug 28; 16(4):218-20, 253. PubMed ID: 8174192
    [Abstract] [Full Text] [Related]

  • 17. [Indication and technique of treatment with aerosols of drugs in a fine mist in long term therapy of chronic bronchitis (author's transl)].
    Herzog H, Keller R.
    Med Klin; 1973 Dec 07; 68(49):1610-7. PubMed ID: 4204452
    [No Abstract] [Full Text] [Related]

  • 18. [The diagnosis and treatment of pulmonary tuberculosis combined with chronic bronchitis in middle-aged and elderly subjects].
    Iashchenko BP, Deribas TB.
    Vrach Delo; 1989 Oct 07; (10):52-5. PubMed ID: 2617985
    [Abstract] [Full Text] [Related]

  • 19. [Disorders of external respiration in patients with pulmonary tuberculosis].
    Gorak AG.
    Vrach Delo; 1972 Nov 07; 11():106-9. PubMed ID: 4659710
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical trial of N-cyclohexyl-N-methyl(-2-amino-3,5-dibromobenzyl)-ammonium chloride associated with antibiotics in therapy of chronic bronchopneumopathies].
    Quilici G, Da Porto R.
    Clin Ter; 1970 Sep 30; 54(6):495-517. PubMed ID: 5527647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.